ArticleBMC geriatrics2026
Interacting and joint effects of frailty and depressive symptoms in relation to risk of cardio-oncology comorbidity in older adults from three prospective cohorts.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile cardiovascular disease and cancer share common risk factors and exhibit complex bidirectional interplay, evidence regarding the interacting and joint effects of frailty and depressive symptoms on the risk of cardio-oncology comorbidity in older adults remains scarce.
objectivesThis study aimed to examine the association between frailty and depressive symptoms with the risk of cardio-oncology comorbidity, and to explore their interacting and joint effects.
methodsThis study harmonized data from three prospective, nationally representative cohort studies: China Health and Retirement Longitudinal Study (CHARLS), the English Longitudinal Study of Ageing (ELSA), and the Health and Retirement Study (HRS). The final analytical sample included 10,937 participants aged ≥ 65 years without baseline cardio-oncology comorbidity. Frailty and depressive symptoms were assessed at baseline. Cardio-oncology comorbidity was ascertained based on self-reported physician diagnoses of cardiovascular disease and cancer. Cox proportional hazards models were utilized to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Multiplicative and additive interaction analyses were conducted, followed by joint association evaluations.
resultsFrailty (CHARLS HR = 1.71; ELSA HR = 1.41; HRS HR = 1.38) and depressive symptoms (CHARLS HR = 1.27; ELSA HR = 1.20; HRS HR = 1.18) were independently associated with significantly increased cardio-oncology comorbidity risk. While interaction analyses demonstrated the absence of significant multiplicative or additive interactions, the joint effect analysis revealed that cardio-oncology comorbidity risk was elevated among individuals with both frailty and depressive symptoms by 80% in CHARLS, 57% in ELSA, and 47% in HRS compared to those with neither condition.
conclusionsConcurrent frailty and depressive symptoms constitute the highest-risk phenotype for cardio-oncology comorbidity in community-dwelling older adults. These findings suggest that combined assessment of frailty and depressive symptoms may improve baseline risk stratification of cardio-oncology comorbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.